A toll-like receptor 9 antagonist improves bladder function and white matter sparing in spinal cord injury

Journal of Neurotrauma

Volumn 31, Issue 21, 2014, Pages 1800-1806

  David, Brian T ^a   Sampath, Sujitha ^a   Dong, Wei ^a   Heiman, Adee ^a   Rella, Courtney E ^a,b   Elkabes, Stella ^a   Heary, Robert F ^a  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

CpG ODN; inflammation; pattern recognition receptors; regeneration; traumatic spinal cord injury

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; CYTIDINE PHOSPHATE GUANOSINE OLIGODEOXYNUCLEOTIDE 2088; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG; OLIGODEOXYRIBONUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CAPACITY; BLADDER DYSFUNCTION; BLADDER FUNCTION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GRAY MATTER; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION; LEUKOCYTE; LUMBAR PUNCTURE; LUNG CONTUSION; MOUSE; NEUROPATHIC PAIN; NONHUMAN; SPINAL CORD INJURY; TISSUE PRESERVATION; URINALYSIS; URINE RETENTION; WHITE MATTER; ANIMAL; ANTAGONISTS AND INHIBITORS; BLADDER; COMPLICATION; DRUG EFFECTS; PATHOLOGY; PATHOPHYSIOLOGY; URINARY RETENTION;

ANIMALS; FEMALE; MICE; OLIGODEOXYRIBONUCLEOTIDES; SPINAL CORD INJURIES; TOLL-LIKE RECEPTOR 9; URINARY BLADDER; URINARY RETENTION; WHITE MATTER;

EID: 84908637880     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2014.3357     Document Type: Article

References (38)

1. Grundy, D., and Russell, J. (1986). ABC of spinal cord injury. Ur-ological management. Br. Med. J. (Clin. Res. Ed.). 292, 249-253.
2. Anderson, K.D. (2004). Targeting recovery: priorities of the spinal cord-injured population. J. Neurotrauma 21, 1371-1383.
3. David, S., Lopez-Vales, R., and Wee Yong, V. (2012). Harmful and beneficial effects of inflammation after spinal cord injury: potential therapeutic implications. Handb. Clin. Neurol. 109, 485-502.
4. Kigerl, K.A., Lai, W., Rivest, S., Hart, R.P., Satoskar, A.R., and Po-povich, P.G. (2007). Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury. J. Neurochem. 102, 37-50.
5. Fang, M., Huang, J.Y., Wang, J., Ling, S.C., Rudd, J.A., Hu, Z.Y., Xu, L.H., Yuan, Z.G., and Han, S. (2011). Anti-neuroinflammatory and neurotrophic effects of combined therapy with annexin II and Reg-2 on injured spinal cord. Neurosignals 19, 16-43.
6. Garcia-Ovejero, D., Gonzalez, S., Paniagua-Torija, B., Lima, A., Molina-Holgado, E., De Nicola, A.F., and Labombarda, F. (2014). Progesterone reduces secondary damage, preserves white matter, and improves locomotor outcome after spinal cord contusion. J. Neuro-trauma 31, 857-871.
7. Glaser, J., Gonzalez, R., Perreau, V.M., Cotman, C.W., and Keirstead, H.S. (2004). Neutralization of the chemokine CXCL10 enhances tissue sparing and angiogenesis following spinal cord injury. J. Neurosci. Res. 77, 701-708.
8. Gonzalez, R., Glaser, J., Liu, M.T., Lane, T.E., and Keirstead, H.S. (2003). Reducing inflammation decreases secondary degeneration and functional deficit after spinal cord injury. Exp. Neurol. 184, 456-463.
9. Gonzalez, R., Hickey, M.J., Espinosa, J.M., Nistor, G., Lane, T.E., and Keirstead, H.S. (2007). Therapeutic neutralization of CXCL10 decreases secondary degeneration and functional deficit after spinal cord injury in mice. Regen. Med. 2, 771-783.
10. Lee, S.M., Rosen, S., Weinstein, P., van Rooijen, N., and Noble-Haeusslein, L.J. (2011). Prevention of both neutrophil and monocyte recruitment promotes recovery after spinal cord injury. J. Neuro-trauma 28, 1893-1907.
11. Bsibsi, M., Ravid, R., Gveric, D., and van Noort, J.M. (2002). Broad expression of Toll-like receptors in the human central nervous system. J. Neuropathol. Exp. Neurol. 61, 1013-1021.
12. Funderburg, N., Luciano, A.A., Jiang, W., Rodriguez, B., Sieg, S.F., and Lederman, M.M. (2008). Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis. PloS One 3, e1915.
13. Hayashi, F., Means, T.K., and Luster, A.D. (2003). Toll-like receptors stimulate human neutrophil function. Blood 102, 2660-2669.
14. He, S., Liang, Y., Shao, F., and Wang, X. (2011). Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway. Proc. Natl. Acad. Sci. U. S. A. 108, 20054-20059.
15. Pineau, I., and Lacroix, S. (2009). Endogenous signals initiating inflammation in the injured nervous system. Glia 57, 351-361.
16. Asea, A., Rehli, M., Kabingu, E., Boch, J.A., Bare, O., Auron, P.E., Stevenson, M.A., and Calderwood, S.K. (2002). Novel signal trans-duction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J. Biol. Chem. 277, 15028-15034.
17. Crack, P.J., and Bray, P.J. (2007). Toll-like receptors in the brain and their potential roles in neuropathology. Immunol. Cell Biol. 85, 476-480.
18. Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., and Akira, S. (2000). A Toll-like receptor recognizes bacterial DNA. Nature 408, 740-745.
19. Thompson, M.R., Kaminski, J.J., Kurt-Jones, E.A., and Fitzgerald, K.A. (2011). Pattern recognition receptors and the innate immune response to viral infection. Viruses 3, 920-940.
20. Chen, K.B., Uchida, K., Nakajima, H., Yayama, T., Hirai, T., Rodriguez Guerrero, A., Kobayashi, S., Ma, W.Y., Liu, S.Y., Zhu, P., and Baba, H. (2011). High-mobility group box-1 and its receptors contribute to proinflammatory response in the acute phase of spinal cord injury in rats. Spine (Phila Pa 1976) 36, 2122-2129.
21. David, B.T., Ratnayake, A., Amarante, M.A., Reddy, N.P., Dong, W., Sampath, S., Heary, R.F., and Elkabes, S. (2013). A toll-like receptor 9 antagonist reduces pain hypersensitivity and the inflammatory response in spinal cord injury. Neurobiol. Dis. 54, 194-205.
22. Basso, D.M., Fisher, L.C., Anderson, A.J., Jakeman, L.B., McTigue, D.M., and Popovich, P.G. (2006). Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J. Neurotrauma 23, 635-659.
23. Anderson, K.D., Sharp, K.G., and Steward, O. (2009). Bilateral cervical contusion spinal cord injury in rats. Exp. Neurol. 220, 9-22.
24. David, B.T., and Steward, O. (2010). Deficits in bladder function following spinal cord injury vary depending on the level of the injury. Exp. Neurol. 226, 128-135.
25. Pikov, V., and Wrathall, J.R. (2001). Coordination of the bladder detrusor and the external urethral sphincter in a rat model of spinal cord injury: effect of injury severity. J. Neurosci. 21, 559-569.
26. Dijkstra, S., Duis, S., Pans, I.M., Lankhorst, A.J., Hamers, F.P., Veldman, H., Bar, P.R., Gispen, W.H., Joosten, E.A., and Geisert, E.E., Jr. (2006). Intraspinal administration of an antibody against CD81 enhances functional recovery and tissue sparing after experimental spinal cord injury. Exp. Neurol. 202, 57-66.
27. Rasband, W., 1997-2007. ImageJ. Vol. 1.38x. National Institutes of Health, Bethesda, Md.
28. Bethea, J.R., Nagashima, H., Acosta, M.C., Briceno, C., Gomez, F., Marcillo, A.E., Loor, K., Green, J., and Dietrich, W.D. (1999). Sys-temically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J. Neurotrauma 16, 851-863.
29. Bracchi-Ricard, V., Lambertsen, K.L., Ricard, J., Nathanson, L., Karmally, S., Johnstone, J., Ellman, D.G., Frydel, B., McTigue, D.M., and Bethea, J.R. (2013). Inhibition of astroglial NF-kappaB enhances oligodendrogenesis following spinal cord injury. J. Neuroinflamma-tion 10, 92.
30. de Rivero Vaccari, J.P., Bastien, D., Yurcisin, G., Pineau, I., Dietrich, W.D., De Koninck, Y., Keane, R.W., and Lacroix, S. (2012). P2X4 receptors influence inflammasome activation after spinal cord injury. J. Neurosci. 32, 3058-3066.
31. Garman, R.H. (2011). Histology of the central nervous system. Tox-icol. Pathol. 39, 22-35.
32. Ek, C.J., Habgood, M.D., Dennis, R., Dziegielewska, K.M., Mallard, C., Wheaton, B., Saunders, N.R. (2012). Pathological changes in the white matter after spinal contusion injury in the rat. PloS One 7, e43484.
33. Estores, I.M. (2003). The consumerSuppl 1, 's perspective and the professional literature: what do persons with spinal cord injury want? J. Rehabil. Res. Dev. 40, 93-98.
34. Cardenas, D.D., Hoffman, J.M., Kirshblum, S., and McKinley, W. (2004). Etiology and incidence of rehospitalization after traumatic spinal cord injury: a multicenter analysis. Arch. Phys. Med. Rehabil. 85, 1757-1763.
35. Lee, K.D., Chow, W.N., Sato-Bigbee, C., Graf, M.R., Graham, R.S., Colello, R.J., Young, H.F., and Mathern, B.E. (2009). FTY720 reduces inflammation and promotes functional recovery after spinal cord injury. J. Neurotrauma 26, 2335-2344.
36. Tanga, F.Y., Nutile-McMenemy, N., and DeLeo, J.A. (2005). The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc. Natl. Acad. Sci. U. S. A. 102, 5856-5861.
37. Kim, D., Kim, M.A., Cho, I.H., Kim, M.S., Lee, S., Jo, E.K., Choi, S.Y., Park, K., Kim, J.S., Akira, S., Na, H.S., Oh, S.B., and Lee, S.J. (2007). A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity. J. Biol. Chem. 282, 14975-14983.
38. Gensel, J.C., Nakamura, S., Guan, Z., van Rooijen, N., Ankeny, D.P., and Popovich, P.G. (2009). Macrophages promote axon regeneration with concurrent neurotoxicity. J. Neurosci. 29, 3956-3968.